Clinical Course of Disease in Participants With FA Cardiomyopathy (CLARITY-FA)
|Oct 30 2024
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich’s Ataxia Who Are Prescribed it by Their Own Doctors
|Oct 29 2024
SKYCLARYS (Omaveloxolone) Pregnancy and Lactation Surveillance Program
|Aug 7 2024
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study (UNIFAI)
|Aug 6 2024
Neurobooth – Digital Phenotyping for Better Measures
|Aug 6 2024
Mechanisms, Markers, and Risk Factors in Friedreich’s Ataxia Heart Disease (FA-HD)
|Aug 1 2024
Further Development and Validation of the Cerebellar Neuropsychiatric Rating Scale (CNRS)
|Mar 19 2024
Characterization of the Cardiac Phenotype of Friedreich’s Ataxia
|Mar 19 2024
Call for Patients with Friedreich Ataxia with upcoming surgical procedure or existing tissue
|Mar 19 2024
Biomarkers in Friedreich’s Ataxia
|Mar 19 2024
Remote Monitoring Study for Friedreich’s Ataxia
|Mar 19 2024
TRACK-FA: A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich’s ataxia